CONCORDE Trial (@lcsmuk) 's Twitter Profile
CONCORDE Trial

@lcsmuk

CONCORDE: a platform study of novel agents in combination with radiotherapy. EudraCT: 2020-000206-28. For information purposes only, unable to respond directly.

ID: 1079628752617914368

calendar_today31-12-2018 06:42:07

83 Tweet

219 Followers

156 Following